Funding Rounds
Confo

Confo Series A (2019, $33M)

Confo

Drug discovery platform based on G-protein-coupled receptors (GPCRs).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $33.58M

Raised Date: 2019-01-01

Investors